Lotus Pharmaceutical Co., Ltd. announced Name of the previous position holder: Arni Hardarson, Resume of the previous position holder: Representative Director of Lotus Pharmaceutical Co., Ltd. Name of the new position holder: Nat Ativitavas, Resume of the new position holder: Director of Innobic (Asia) Company Limited. Reason for the change: Alvogen Emerging Markets Holdings Limited assigned a new representative director. Effective date of the new appointment: 2023/09/04.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
281 TWD | -0.53% | -3.60% | +3.31% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.31% | 2.32B | |
+35.64% | 727B | |
-6.85% | 354B | |
+15.59% | 328B | |
+0.16% | 277B | |
+13.79% | 243B | |
+7.46% | 205B | |
-5.93% | 203B | |
+4.50% | 164B | |
-1.22% | 164B |
- Stock Market
- Equities
- 1795 Stock
- News Lotus Pharmaceutical Co., Ltd.
- Lotus Pharmaceutical Co., Ltd. Announces Director Changes